California Public Employees Retirement System Has $211.15 Million Stock Position in Lam Research Corporation $LRCX

California Public Employees Retirement System reduced its position in shares of Lam Research Corporation (NASDAQ:LRCX) by 21.3% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,169,202 shares of the semiconductor company’s stock after selling 586,605 shares during the period. California Public Employees Retirement System’s holdings in Lam Research were worth $211,150,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Brighton Jones LLC boosted its holdings in Lam Research by 1,032.4% during the fourth quarter. Brighton Jones LLC now owns 14,189 shares of the semiconductor company’s stock valued at $1,025,000 after acquiring an additional 12,936 shares during the period. AlphaCore Capital LLC lifted its position in shares of Lam Research by 118.8% during the 1st quarter. AlphaCore Capital LLC now owns 6,279 shares of the semiconductor company’s stock worth $458,000 after purchasing an additional 3,409 shares during the last quarter. Townsquare Capital LLC boosted its stake in Lam Research by 13.2% during the 1st quarter. Townsquare Capital LLC now owns 90,326 shares of the semiconductor company’s stock valued at $6,567,000 after purchasing an additional 10,539 shares during the period. Zions Bancorporation National Association UT bought a new stake in Lam Research during the 1st quarter valued at approximately $616,000. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Lam Research in the 1st quarter valued at approximately $245,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Trading Up 1.0%

Shares of LRCX stock opened at $158.70 on Monday. The firm has a fifty day moving average of $150.02 and a 200-day moving average of $117.59. The stock has a market cap of $199.33 billion, a price-to-earnings ratio of 34.96, a P/E/G ratio of 1.63 and a beta of 1.77. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $167.15. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the previous year, the business earned $0.86 EPS. The firm’s revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, equities research analysts forecast that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 7th. Stockholders of record on Wednesday, December 3rd will be paid a $0.26 dividend. This represents a $1.04 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, December 3rd. Lam Research’s dividend payout ratio is currently 22.91%.

Insider Buying and Selling

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the stock in a transaction on Friday, November 14th. The stock was sold at an average price of $150.60, for a total transaction of $6,036,048.00. Following the completion of the transaction, the chief financial officer directly owned 987,237 shares in the company, valued at $148,677,892.20. This represents a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total value of $7,249,191.00. Following the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders sold 102,608 shares of company stock valued at $14,916,496. 0.31% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

LRCX has been the subject of several research reports. Wall Street Zen cut Lam Research from a “buy” rating to a “hold” rating in a research report on Saturday, November 8th. Morgan Stanley upped their target price on shares of Lam Research from $137.00 to $158.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 2nd. Hsbc Global Res upgraded shares of Lam Research to a “hold” rating in a research report on Tuesday, September 30th. Needham & Company LLC boosted their price objective on shares of Lam Research from $150.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Finally, Erste Group Bank started coverage on shares of Lam Research in a research note on Thursday, August 14th. They issued a “buy” rating for the company. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Lam Research has an average rating of “Moderate Buy” and an average price target of $152.87.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.